Collegium Pharmaceutical, Inc.
COLL
$38.58
-$0.19-0.49%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 5.76% | -2.30% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 5.76% | -2.30% | |||
| Cost of Revenue | 3.29% | -11.31% | |||
| Gross Profit | 6.10% | -0.92% | |||
| SG&A Expenses | -4.87% | 30.31% | |||
| Depreciation & Amortization | 0.00% | 0.00% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -1.97% | 10.87% | |||
| Operating Income | 54.39% | -44.10% | |||
| Income Before Tax | 445.32% | -81.92% | |||
| Income Tax Expenses | 615.18% | -85.10% | |||
| Earnings from Continuing Operations | 395.78% | -80.72% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 395.78% | -80.72% | |||
| EBIT | 54.39% | -44.10% | |||
| EBITDA | 16.43% | -19.16% | |||
| EPS Basic | 395.66% | -80.55% | |||
| Normalized Basic EPS | 236.13% | -74.23% | |||
| EPS Diluted | 392.29% | -80.01% | |||
| Normalized Diluted EPS | 182.82% | -68.82% | |||
| Average Basic Shares Outstanding | 0.05% | -0.89% | |||
| Average Diluted Shares Outstanding | 18.99% | -18.12% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||